CClinicalTrials.gg
Not yet recruitingNCT07737899PrimPalUpdated Aug 3, 2026

Primary Palliative Care - a Feasibility Cluster Trial

An interventional study of Primary Palliative Care Complex Intervention (PrimPal) in Palliative Care, Primary Palliative Care and Advanced Cancer, sponsored by University of Coimbra. Not yet recruiting at 2 sites in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-08-03.

Sponsored by University of Coimbra · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
30
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

This feasibility cluster-controlled randomized trial (RCT) evaluates a complex intervention for the delivery of primary palliative care in Family Health Units (FHUs). The intervention consists of training General Practitioners (GPs) in palliative care through a 30 hour e-learning program and implementing a structured consultation model (4 consultations over 12 weeks) for adult patients with advanced chronic illness. One FHU will receive the intervention and one FHU will follow usual care. The primary goal is to assess feasibility metrics (GP adherence, patient recruitment rate, and patient retention rate), which will inform the design of a subsequent full-scale cluster RCT.

Read the detailed description

Background: Demographic ageing and the rising burden of chronic disease have dramatically increased the need for palliative care. Most patients with palliative care needs are cared for in primary health care (PHC) settings, yet GPs often lack training and systematic tools to identify and manage these patients. The Principal Investigator developed a complex intervention combining GP training and a new consultation model during doctoral research, demonstrating promising results (reduction in physical and psychological symptoms) in a before-after study (published in Palliative Medicine, DOI: 10.1177/02692163231219682). The present feasibility trial is the next methodological step before undertaking a full-scale cluster RCT.

Design: Feasibility cluster-controlled RCT with an embedded qualitative component (mixed-methods). Randomisation occurs at the cluster (FHU) level. Two FHUs from ULS Coimbra (central Portugal) will be recruited: one allocated to the intervention arm and one to the control (usual care) arm.

Intervention: GPs in the intervention FHU will complete a 30hour e-learning training programme covering palliative care communication, symptom management, and patient assessment/control. After training, each GP will apply the new structured consultation model to recruited patients over 12 weeks (4 consultations). The model is grounded in the 4th edition of the National Consensus Project's Clinical Practice Guidelines for Quality Palliative Care and WONCA's core competencies for GPs in palliative care.

Control: GPs in the control FHU will follow usual care without any specific palliative care training or structured consultation model.

Participants: Adult patients (≥18 years) on the list of recruited GPs with a diagnosis of: advanced-stage neoplasm (metastatic cancer), COPD GOLD III/IV, Congestive Heart Failure NYHA III/IV, or Chronic Kidney Disease stage IV/V.

Feasibility outcomes: GP implementation rate (primary), patient recruitment rate, and patient retention rate will be assessed at baseline (T0), week 6 (T1), and week 12 (T2). Qualitative data will be collected through interviews with GPs and patients to explore perceived barriers and benefits of the intervention.

Significance: Results will be used to refine the intervention and study procedures, and to power a future definitive cluster RCT.

02

Conditions studied

  • Palliative Care
  • Primary Palliative Care
  • Advanced Cancer
  • Chronic Obstructive Pulmonary Disease (COPD)
  • Congestive Heart Failure Chronic
  • Chronic Kidney Disease (Stages 4 and 5)

Keywords

  • Palliative care
  • Primary Palliative Care
  • General practice
  • Family medicine
  • Feasibility study
  • Cluster randomized controlled trial
  • Complex intervention
  • Chronic disease
03

In context

Pulmonary Disease, Chronic Obstructive

4,131 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 697 are open to participants now.

This study's planned enrollment of 30 is below the median of 70 across 2,926 interventional studies indexed under Pulmonary Disease, Chronic Obstructive.

Browse Pulmonary Disease, Chronic Obstructive studies →

Lead sponsor

University of Coimbra is the lead sponsor of 84 studies on the registry; 25 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Aged 18 years or older.
  • Enrolled as a patient on the list of a recruited General Practitioner in one of the participating Family Health Units.
  • Diagnosed with one or more of the following advanced chronic conditions:
  • Advanced-stage neoplasm (metastatic/stage IV cancer);
  • Chronic Obstructive Pulmonary Disease (COPD) - GOLD classification III or IV;
  • Congestive Heart Failure (CHF) - New York Heart Association (NYHA) functional classification III or IV;
  • Chronic Kidney Disease (CKD) - stage IV or V.

Exclusion criteria

Exclusion Criteria:

  • Refusal to provide informed consent or to participate in the study at any point.
  • Disease severity requiring urgent medical intervention (acute crisis/emergency care need at time of recruitment).
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
30 participants (estimated)

Study arms

  • Experimental
    Primary Palliative Care Consultation

    General Practitioners in the intervention FHU complete a 30hour e-learning training programme in palliative care and apply a new structured consultation model over 12 weeks (4 consultations) with recruited patients.

    Other: Primary Palliative Care Complex Intervention (PrimPal)

  • No intervention
    Control (Usual Care)

    GPs in the control FHU deliver usual palliative care without specific training or structured consultation model.

Interventions

  • OtherPrimary Palliative Care Complex Intervention (PrimPal)

    1. GPs will receive an e-learning palliative care training programme with a 30-h load, including topics such as the role of communication, the main problems and symptoms of patients with palliative care needs and how to assess and control them. Additionally, the programme covered how to apply the newly developed medical consultation model and how to use the Integrated Palliative Care Outcome Scale (IPOS) patient version 2. Primary palliative care consultation model divided into five areas (1) summarizing clinical information, (2) objective symptoms' management, (3) assessment and coding of chronic diseases and symptoms, (4) planning clinical approach and (5) addressing other problems/concerns - 4 consultations over 12 weeks.

06

What researchers measure

Primary outcomes

  1. GP Feasibility Rate (Implementation Rate)

    Percentage of GPs in the intervention arm who successfully implement the new consultation model with their recruited patients (excluding failures due to reasons unrelated to the physician, e.g., patient death or withdrawal). Feasibility is considered demonstrated if ≥70% of GPs complete the model with at least 80% of their recruited patients.

    Time frame: 12 weeks (from start of intervention to end of consultation cycle - Week 12 / T2)

Secondary outcomes

  1. Patient Recruitment Rate

    Percentage of contacted eligible patients who agree to participate in the study.

    Time frame: Baseline (T0) - during recruitment period

  2. Patient Retention Rate

    Percentage of enrolled patients who complete all 4 consultations and remain in the study until week 12.

    Time frame: Week 12 (T2)

  3. Perceived Barriers to Implementation

    Qualitative exploration of obstacles experienced by GPs and patients in the implementation of the intervention, assessed via semi-structured interviews

    Time frame: Week 12 (T2) - end of intervention

  4. Perceived Benefits of the Intervention

    Qualitative exploration of the benefits perceived by GPs and patients from the intervention, assessed via semi-structured interviews.

    Time frame: Week 12 (T2) - end of intervention

07

Study locations

2 sites
  • Family Health Unit 1 - ULS Coimbra (Intervention)
    Coimbra, Portugal
  • Family Health Unit 2 - ULS Coimbra (Control)
    Coimbra, Portugal
08

References and documents

Publications

  • Seica Cardoso C, Prazeres F, Oliveiros B, Nunes C, Simoes P, Aires C, Rita P, Penetra J, Lopes P, Alcobia S, Baptista S, Venancio C, Gomes B. Feasibility and effectiveness of a two-tiered intervention involving training and a new consultation model for patients with palliative care needs in primary care: A before-after study. Palliat Med. 2024 Sep;38(8):842-852. doi: 10.1177/02692163231219682. Epub 2024 Jan 16. PubMed 38226491 ↗
  • Seica Cardoso C, Prazeres F, Nunes C, Simoes P, Aires C, Rita P, Penetra J, Lopes P, Alcobia S, Gomes B. Impact of a complex intervention in primary care for patients with palliative care needs in their healthcare utilization: a before-after study. Prim Health Care Res Dev. 2026 Jan 30;27:e15. doi: 10.1017/S1463423625100777. PubMed 41612825 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 3, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07737899
Lead sponsor
University of Coimbra
Collaborators
Unidade Local de Saúde de Coimbra, EPE
Responsible party
Carlos Seiça Cardoso (Principal Investigator, University of Coimbra) — Principal investigator
First posted
Jul 30, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Feb 28, 2027 (estimated)
Completion
Aug 31, 2027 (estimated)
Last update
Aug 3, 2026

Study contacts

Carlos S Cardoso, PhD
Contact
carlosseicacardoso@uc.pt
00351 239 857 700

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Jul 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion